Esteve S.A. (Laboratorios Del Dr. Esteve S.A.)

13 articles with Esteve S.A. (Laboratorios Del Dr. Esteve S.A.)

• Esteve acquires German proprietary, specialty, hospital-focused company Riemser and expands its presence in Europe

  1/8/2020

  The acquisition provides Esteve with greater pharmaceutical presence in Europe's main markets and a portfolio of proprietary specialty products for hospital use.

• Esteve S.A. (Laboratorios Del Dr. Esteve S.A.) Gains Sample Management Efficiencies Using Titian Software’s Mosaic Software

  8/15/2016

• Esteve S.A. (Laboratorios Del Dr. Esteve S.A.) And UAB Expand Their Research To Two New Gene Therapies For Sanfilippo B Syndrome And Hunter Syndrome

  2/25/2016

• Esteve S.A. (Laboratorios Del Dr. Esteve S.A.) Could Bank $1 Billion From Mundipharma AG, Purdue Pharma L.P. Pain Pact

  1/12/2015

• Esteve S.A. (Laboratorios Del Dr. Esteve S.A.) And U.A.B. Advances In Their Program To Develop A Cure For Sanfilippo A Syndrome

  3/11/2014

• REGENX Biosciences, LLC And Esteve S.A. (Laboratorios Del Dr. Esteve S.A.) Enter Into License Agreement For Development Of Treatments For Serious, Rare Lysosomal Storage Disorder Using NAV® rAAV9 Vectors

  3/10/2014

• Esteve S.A. (Laboratorios Del Dr. Esteve S.A.) Announces Positive Results From Its Phase 2 Clinical Study of E-58425 in Acute Pain

  10/16/2013

• Esteve S.A. (Laboratorios Del Dr. Esteve S.A.) Announces Publication of Key Preclinical Data for a Novel Oral, First-in-class New Chemical Entity (NCE) Sigma-1 Receptor Antagonist (E-52862), that has Completed Phase I and Initiated its Phase II Clinical T

  7/17/2012

• Esteve S.A. (Laboratorios Del Dr. Esteve S.A.) Opens Second Factory in China

  10/28/2010

• Recordati S.p.A Signs Co-Marketing Agreement With Esteve S.A. (Laboratorios Del Dr. Esteve S.A.) In Spain For Pitavastatin

  4/7/2010

• Esteve S.A. (Laboratorios Del Dr. Esteve S.A.): Innate Immune Mechanisms Can Control Disease Progression In HIV-Positive Patients

  2/26/2010

• Esteve S.A. (Laboratorios Del Dr. Esteve S.A.) And IRSICAIXA Sign Partnership Agreement For The Development Of A Vaccine Against AIDS

  1/9/2009

• Wex Pharmaceuticals Inc. and Esteve S.A. (Laboratorios Del Dr. Esteve S.A.) Terminate Collaboration on Tetrodotoxin

  5/14/2007